查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
微生物組定序服務市場：趨勢、機會與競爭分析 [2023-2028]
市場調查報告書
商品編碼
1341985

微生物組定序服務市場：趨勢、機會與競爭分析 [2023-2028]

Microbiome Sequencing Service Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

微生物組定序服務市場趨勢與預測

預計到2028年，全球微生物組定序服務市場將達到 24 億美元，2023年至2028年年複合成長率為 12.4%。該市場的主要促進因素是對宏基因組分析技術的需求不斷成長、對人類微生物組療法市場開拓的高度關注以及與先進測序設備相關的高成本。全球微生物組定序服務市場前景廣闊，為製藥公司、生技公司和學術研究機構帶來商機。

微生物組定序服務市場洞察

  • Lucintel 是一種高度並行的架構，能夠同時對數百萬個擴增子進行定序，並且對研究腸道、皮膚和其他器官中的細菌種群(每個細菌種群都具有不同的微生物指紋)感興趣，預測合成定序（SBS）在預測期內仍將是成長最快的區隔。此外，它是一些商業公司廣泛使用的技術。
  • 在這個市場中，由於研究和領域廣泛使用微生物組定序服務進行蛋白質和小分子測試，學術和研究機構仍將是最大的最終用途產業領域。
  • 由於其完善的研究框架、尖端的技術發展以及該地區對精準醫療的需求不斷成長，北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球微生物組定序服務市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2017-2028年市場趨勢及預測分析

  • 宏觀經濟趨勢（2017-2022）與預測（2023-2028）
  • 全球微生物組定序服務市場趨勢（2017-2022）與預測（2023-2028）
  • 依技術分類的全球微生物定序服務市場
    • 合成定序 (SBS)
    • 連接定序 (SBL)
    • 奈米孔定序
    • 桑格序列測定
    • 其他
  • 依類型分類的全球微生物組定序服務市場
    • 擴增子序列測定
    • 全基因組序列測定
    • 霰彈槍序列
    • 其他
  • 依最終用途行業分類的全球微生物組定序服務市場
    • 製藥和生物技術公司
    • 學術研究所
    • 其他

第4章 2017-2028年分地區市場趨勢及預測分析

  • 全球微生物組定序服務市場（依地區）
  • 北美微生物組定序服務市場
  • 歐洲微生物組定序服務市場
  • 歐洲微生物組定序服務市場
  • 亞太微生物組定序服務市場
  • 其他區域微生物組定序服務市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球微生物組定序服務市場成長機會（依技術）
    • 全球微生物組定序服務市場成長機會（依類型）
    • 全球微生物組定序服務市場成長機會（依最終用途產業）
    • 全球微生物組定序服務市場成長機會（依地區）
  • 全球微生物組定序服務市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球微生物組定序服務市場容量擴張
    • 全球微生物組定序服務市場的合併、收購及合資企業
    • 認證和許可

第7章 主要企業概況

  • Microbiome Insights
  • Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corporation
  • MR DNA
  • Metabiomics
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome
簡介目錄

Microbiome Sequencing Service Market Trends and Forecast

The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes. The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 12.4% from 2023 to 2028. The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.

A more than 150-page report is developed to help in your business decisions.

Microbiome Sequencing Service Market by Segment

The study includes trends and forecast for the global microbiome sequencing service market by technology, type, and end use industry, and region.

Microbiome Sequencing Service Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Nanopore Sequencing
  • Sanger Sequencing
  • Others

Microbiome Sequencing Service Market by Type [Shipment Analysis by Value from 2017 to 2028]:

  • Amplicon Sequencing
  • Whole-Genome Sequencing
  • Shotgun Sequencing
  • Others

Microbiome Sequencing Service Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

List of Microbiome Sequencing Service Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, microbiome sequencing service companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiome sequencing service companies profiled in this report include:

  • Microbiome Insights
  • Baseclear
  • Clinical-Microbiomics
  • Merieux NutriSciences Corporation
  • MR DNA
  • Metabiomics
  • Rancho BioSciences
  • Second Genome
  • Zymo Research Corporation
  • uBiome

Microbiome Sequencing Service Market Insights

  • Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
  • Within this market, academic and research institutes will remain the largest end use industry segment due to extensive utilization of microbiome sequencing services for the examination of proteins and small molecules within the research and academic sectors.
  • North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.

Features of the Global Microbiome Sequencing Service Market

  • Market Size Estimates: Microbiome sequencing service market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Microbiome sequencing service market size by various segments, such as by technology, type, end use industry, and region in terms of value ($B).
  • Regional Analysis: Microbiome sequencing service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different technologies, types, end use industries, and regions for the microbiome sequencing service market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiome sequencing service market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q.1. What is the microbiome sequencing service market size?
  • Answer: The global microbiome sequencing service market is expected to reach an estimated $2.4 billion by 2028.
  • Q.2. What is the growth forecast for microbiome sequencing service market?
  • Answer: The global microbiome sequencing service market is expected to grow with a CAGR of 12.4% from 2023 to 2028
  • Q.3. What are the major drivers influencing the growth of the microbiome sequencing service market?
  • Answer: The major drivers for this market are increasing demand for metagenomic sequencing technology, high concentration on development of human microbiome therapeutics, as well as high costs associated with sophisticated sequencing instruments.
  • Q4. What are the major segments for microbiome sequencing service market?
  • Answer: The future of the global microbiome sequencing service market looks promising with opportunities in pharmaceutical and biotechnology companies and academic and research institutes.
  • Q5. Who are the key microbiome sequencing service companies?
  • Answer: Some of the key microbiome sequencing service companies are as follows:
    • Microbiome Insights
    • Baseclear
    • Clinical-Microbiomics
    • Merieux NutriSciences Corporation
    • MR DNA
    • Metabiomics
    • Rancho BioSciences
    • Second Genome
    • Zymo Research Corporation
    • uBiome
  • Q6. Which microbiome sequencing service market segment will be the largest in future?
  • Answer: Lucintel forecasts that sequencing by synthesis (SBS) will remain the highest growing segment over the forecast period due to its highly parallel structure that enables the simultaneous sequencing of millions of amplicons and increased interest in studying bacterial populations in the gut, skin, and other organs, each of which has a distinct microbial fingerprint. Moreover, it is an extensively used method by several commercial companies.
  • Q7. In microbiome sequencing service market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to well-developed research framework, cutting-edge technological progress, and the growing need for precision medicines in this region.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global microbiome sequencing service market by technology (sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, sanger sequencing, and others), type (amplicon sequencing, whole-genome sequencing, shotgun sequencing, and others), end use industry (pharmaceutical and biotechnology companies, academic and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Microbiome Sequencing Service Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Microbiome Sequencing Service Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Microbiome Sequencing Service Market by Technology
    • 3.3.1: Sequencing by Synthesis (SBS)
    • 3.3.2: Sequencing by Ligation (SBL)
    • 3.3.3: Nanopore Sequencing
    • 3.3.4: Sanger Sequencing
    • 3.3.5: Others
  • 3.4: Global Microbiome Sequencing Service Market by Type
    • 3.4.1: Amplicon Sequencing
    • 3.4.2: Whole-Genome Sequencing
    • 3.4.3: Shotgun Sequencing
    • 3.4.4: Others
  • 3.5: Global Microbiome Sequencing Service Market by End Use Industry
    • 3.5.1: Pharmaceutical and Biotechnology Companies
    • 3.5.2: Academic and Research Institutes
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Microbiome Sequencing Service Market by Region
  • 4.2: North American Microbiome Sequencing Service Market
    • 4.2.1: North American Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.2.2: North American Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
  • 4.3: European Microbiome Sequencing Service Market
  • 4.3: European Microbiome Sequencing Service Market
    • 4.3.1: European Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.3.2: European Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
  • 4.4: APAC Microbiome Sequencing Service Market
    • 4.4.1: APAC Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.4.2: APAC Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others
  • 4.5: ROW Microbiome Sequencing Service Market
    • 4.5.1: ROW Microbiome Sequencing Service Market by Technology: Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Nanopore Sequencing Sanger Sequencing
    • 4.5.2: ROW Microbiome Sequencing Service Market by Type: Amplicon Sequencing, Whole-Genome Sequencing, Shotgun Sequencing, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Microbiome Sequencing Service Market by Technology
    • 6.1.2: Growth Opportunities for the Global Microbiome Sequencing Service Market by Type
    • 6.1.3: Growth Opportunities for the Global Microbiome Sequencing Service Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Microbiome Sequencing Service Market by Region
  • 6.2: Emerging Trends in the Global Microbiome Sequencing Service Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Microbiome Sequencing Service Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiome Sequencing Service Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Microbiome Insights
  • 7.2: Baseclear
  • 7.3: Clinical-Microbiomics
  • 7.4: Merieux NutriSciences Corporation
  • 7.5: MR DNA
  • 7.6: Metabiomics
  • 7.7: Rancho BioSciences
  • 7.8: Second Genome
  • 7.9: Zymo Research Corporation
  • 7.10: uBiome